Goldman Sachs analyst Thiago Bortoluci upgrades BRF (NYSE:BRFS) from Sell to Neutral.
Oppenheimer Maintains Outperform on Seagen, Lowers Price Target to $178
Oppenheimer analyst Jay Olson maintains Seagen (NASDAQ:SGEN) with a Outperform and lowers the price target from $188 to $178.